Man Wang, Fei Yu, Yuan Zhang, Lei Zhang, Wenguang Chang, Kun Wang. Front Cell Dev Biol 2022
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
Vaccine Therapies for Cancer: Then and Now.
Michael A Morse, William R Gwin, Duane A Mitchell. Target Oncol 2021
Michael A Morse, William R Gwin, Duane A Mitchell. Target Oncol 2021
33
An overview of precision oncology basket and umbrella trials for clinicians.
Jay J H Park, Grace Hsu, Ellie G Siden, Kristian Thorlund, Edward J Mills. CA Cancer J Clin 2020
Jay J H Park, Grace Hsu, Ellie G Siden, Kristian Thorlund, Edward J Mills. CA Cancer J Clin 2020
33
Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety-A Systematic Review with Meta-Analysis.
Wen-Liang Yu, Zi-Chun Hua. Cancers (Basel) 2019
Wen-Liang Yu, Zi-Chun Hua. Cancers (Basel) 2019
33
Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.
Ban Qi Tay, Quentin Wright, Rahul Ladwa, Christopher Perry, Graham Leggatt, Fiona Simpson, James W Wells, Benedict J Panizza, Ian H Frazer, Jazmina L G Cruz. Vaccines (Basel) 2021
Ban Qi Tay, Quentin Wright, Rahul Ladwa, Christopher Perry, Graham Leggatt, Fiona Simpson, James W Wells, Benedict J Panizza, Ian H Frazer, Jazmina L G Cruz. Vaccines (Basel) 2021
33
Overcoming Chemotherapy Resistance in SCLC.
Brett H Herzog, Siddhartha Devarakonda, Ramaswamy Govindan. J Thorac Oncol 2021
Brett H Herzog, Siddhartha Devarakonda, Ramaswamy Govindan. J Thorac Oncol 2021
33
Recombinant Viruses for Cancer Therapy.
Daria S Chulpanova, Valeriya V Solovyeva, Kristina V Kitaeva, Stephen P Dunham, Svetlana F Khaiboullina, Albert A Rizvanov. Biomedicines 2018
Daria S Chulpanova, Valeriya V Solovyeva, Kristina V Kitaeva, Stephen P Dunham, Svetlana F Khaiboullina, Albert A Rizvanov. Biomedicines 2018
33
Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.
Elizabeth A Mittendorf, Biao Lu, Michelle Melisko, Julie Price Hiller, Igor Bondarenko, Adrian Murray Brunt, Grybach Sergii, Katarina Petrakova, George E Peoples. Clin Cancer Res 2019
Elizabeth A Mittendorf, Biao Lu, Michelle Melisko, Julie Price Hiller, Igor Bondarenko, Adrian Murray Brunt, Grybach Sergii, Katarina Petrakova, George E Peoples. Clin Cancer Res 2019
33
Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer.
Cristina Gutierrez, Colleen McEvoy, Laveena Munshi, R Scott Stephens, Michael E Detsky, Joseph L Nates, Stephen M Pastores. Crit Care Med 2020
Cristina Gutierrez, Colleen McEvoy, Laveena Munshi, R Scott Stephens, Michael E Detsky, Joseph L Nates, Stephen M Pastores. Crit Care Med 2020
33
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.
Milica Nedeljković, Ana Damjanović. Cells 2019
Milica Nedeljković, Ana Damjanović. Cells 2019
33
Viruses with oncolytic properties and their adaptation to tumors.
A E MOORE. Ann N Y Acad Sci 1952
A E MOORE. Ann N Y Acad Sci 1952
33
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries.
Camillo Porta, Antonin Levy, Robert Hawkins, Daniel Castellano, Joaquim Bellmunt, Paul Nathan, Ray McDermott, John Wagstaff, Paul Donnellan, John McCaffrey,[...]. Cancer Med 2014
Camillo Porta, Antonin Levy, Robert Hawkins, Daniel Castellano, Joaquim Bellmunt, Paul Nathan, Ray McDermott, John Wagstaff, Paul Donnellan, John McCaffrey,[...]. Cancer Med 2014
33
Molecular targeted therapy: Treating cancer with specificity.
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon. Eur J Pharmacol 2018
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon. Eur J Pharmacol 2018
33
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Daniel W Lee, Bianca D Santomasso, Frederick L Locke, Armin Ghobadi, Cameron J Turtle, Jennifer N Brudno, Marcela V Maus, Jae H Park, Elena Mead, Steven Pavletic,[...]. Biol Blood Marrow Transplant 2019
Daniel W Lee, Bianca D Santomasso, Frederick L Locke, Armin Ghobadi, Cameron J Turtle, Jennifer N Brudno, Marcela V Maus, Jae H Park, Elena Mead, Steven Pavletic,[...]. Biol Blood Marrow Transplant 2019
33
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.
Frank Kroschinsky, Friedrich Stölzel, Simone von Bonin, Gernot Beutel, Matthias Kochanek, Michael Kiehl, Peter Schellongowski. Crit Care 2017
Frank Kroschinsky, Friedrich Stölzel, Simone von Bonin, Gernot Beutel, Matthias Kochanek, Michael Kiehl, Peter Schellongowski. Crit Care 2017
33
Current Trends in Cancer Immunotherapy.
Ivan Y Filin, Valeriya V Solovyeva, Kristina V Kitaeva, Catrin S Rutland, Albert A Rizvanov. Biomedicines 2020
Ivan Y Filin, Valeriya V Solovyeva, Kristina V Kitaeva, Catrin S Rutland, Albert A Rizvanov. Biomedicines 2020
33
Epidermal growth factor receptor targeting in cancer.
John Mendelsohn, Jose Baselga. Semin Oncol 2006
John Mendelsohn, Jose Baselga. Semin Oncol 2006
33
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma.
Siler H Panowski, Tracy C Kuo, Yi Zhang, Amy Chen, Tao Geng, Laura Aschenbrenner, Cris Kamperschroer, Edward Pascua, Wei Chen, Kathy Delaria,[...]. Mol Cancer Ther 2019
Siler H Panowski, Tracy C Kuo, Yi Zhang, Amy Chen, Tao Geng, Laura Aschenbrenner, Cris Kamperschroer, Edward Pascua, Wei Chen, Kathy Delaria,[...]. Mol Cancer Ther 2019
33
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities.
Joseph W Fischer, Nirjal Bhattarai. Front Immunol 2021
Joseph W Fischer, Nirjal Bhattarai. Front Immunol 2021
33
Recent Advances in Oligonucleotide Therapeutics in Oncology.
Haoyu Xiong, Rakesh N Veedu, Sarah D Diermeier. Int J Mol Sci 2021
Haoyu Xiong, Rakesh N Veedu, Sarah D Diermeier. Int J Mol Sci 2021
33
Therapeutic Advances in Oncology.
Jinsha Liu, Priyanka Pandya, Sepideh Afshar. Int J Mol Sci 2021
Jinsha Liu, Priyanka Pandya, Sepideh Afshar. Int J Mol Sci 2021
33
The Oncolytic Virus in Cancer Diagnosis and Treatment.
Guo-Dong Cao, Xiao-Bo He, Qiang Sun, Sihan Chen, Ke Wan, Xin Xu, Xudong Feng, Peng-Ping Li, Bo Chen, Mao-Ming Xiong. Front Oncol 2020
Guo-Dong Cao, Xiao-Bo He, Qiang Sun, Sihan Chen, Ke Wan, Xin Xu, Xudong Feng, Peng-Ping Li, Bo Chen, Mao-Ming Xiong. Front Oncol 2020
33
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, Christina Lacchetti, Bryan J Schneider, Milan Anadkat, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau,[...]. J Clin Oncol 2021
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, Christina Lacchetti, Bryan J Schneider, Milan Anadkat, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau,[...]. J Clin Oncol 2021
33
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.
Zhaoying Fu, Jim Xiang. Int J Mol Sci 2020
Zhaoying Fu, Jim Xiang. Int J Mol Sci 2020
33
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
Gaurav Singal, Peter G Miller, Vineeta Agarwala, Gerald Li, Gaurav Kaushik, Daniel Backenroth, Anala Gossai, Garrett M Frampton, Aracelis Z Torres, Erik M Lehnert,[...]. JAMA 2019
Gaurav Singal, Peter G Miller, Vineeta Agarwala, Gerald Li, Gaurav Kaushik, Daniel Backenroth, Anala Gossai, Garrett M Frampton, Aracelis Z Torres, Erik M Lehnert,[...]. JAMA 2019
33
Pharmacovigilance in oncology.
Paolo Baldo, Giulia Fornasier, Laura Ciolfi, Ivana Sartor, Sara Francescon. Int J Clin Pharm 2018
Paolo Baldo, Giulia Fornasier, Laura Ciolfi, Ivana Sartor, Sara Francescon. Int J Clin Pharm 2018
33
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis.
Lars Michel, Raluca I Mincu, Simone M Mrotzek, Sebastian Korste, Ulrich Neudorf, Tienush Rassaf, Matthias Totzeck. ESC Heart Fail 2020
Lars Michel, Raluca I Mincu, Simone M Mrotzek, Sebastian Korste, Ulrich Neudorf, Tienush Rassaf, Matthias Totzeck. ESC Heart Fail 2020
33
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).
Raza M Alvi, Matthew J Frigault, Michael G Fradley, Michael D Jain, Syed S Mahmood, Magid Awadalla, Dae Hyun Lee, Daniel A Zlotoff, Lili Zhang, Zsofia D Drobni,[...]. J Am Coll Cardiol 2019
Raza M Alvi, Matthew J Frigault, Michael G Fradley, Michael D Jain, Syed S Mahmood, Magid Awadalla, Dae Hyun Lee, Daniel A Zlotoff, Lili Zhang, Zsofia D Drobni,[...]. J Am Coll Cardiol 2019
33
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
S Amanpour. Arch Razi Inst 2021
S Amanpour. Arch Razi Inst 2021
33
Progress in cancer chemotherapy with special stress on molecular-targeted therapy.
Nagahiro Saijo. Jpn J Clin Oncol 2010
Nagahiro Saijo. Jpn J Clin Oncol 2010
33
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
M Hidalgo, L L Siu, J Nemunaitis, J Rizzo, L A Hammond, C Takimoto, S G Eckhardt, A Tolcher, C D Britten, L Denis,[...]. J Clin Oncol 2001
M Hidalgo, L L Siu, J Nemunaitis, J Rizzo, L A Hammond, C Takimoto, S G Eckhardt, A Tolcher, C D Britten, L Denis,[...]. J Clin Oncol 2001
33
Targeted therapies: a new generation of cancer treatments.
David E Gerber. Am Fam Physician 2008
David E Gerber. Am Fam Physician 2008
33
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome.
Chelsea Kotch, David Barrett, David T Teachey. Expert Rev Clin Immunol 2019
Chelsea Kotch, David Barrett, David T Teachey. Expert Rev Clin Immunol 2019
33
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success.
Marina Elena Cazzaniga, Romano Danesi, Corrado Girmenia, Pietro Invernizzi, Alessandra Elvevi, Massimo Uguccioni. Breast Cancer Res Treat 2019
Marina Elena Cazzaniga, Romano Danesi, Corrado Girmenia, Pietro Invernizzi, Alessandra Elvevi, Massimo Uguccioni. Breast Cancer Res Treat 2019
33
Cancer immunotherapy: harnessing the immune system to battle cancer.
Yiping Yang. J Clin Invest 2015
Yiping Yang. J Clin Invest 2015
33
Highlights in Resistance Mechanism Pathways for Combination Therapy.
João M A Delou, Alana S O Souza, Leonel C M Souza, Helena L Borges. Cells 2019
João M A Delou, Alana S O Souza, Leonel C M Souza, Helena L Borges. Cells 2019
33
Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
Brandon Douglas Brown, Francesco Paolo Tambaro, Mira Kohorst, Linda Chi, Kris Michael Mahadeo, Priti Tewari, Demetrios Petropoulos, John M Slopis, Zsila Sadighi, Sajad Khazal. Front Oncol 2021
Brandon Douglas Brown, Francesco Paolo Tambaro, Mira Kohorst, Linda Chi, Kris Michael Mahadeo, Priti Tewari, Demetrios Petropoulos, John M Slopis, Zsila Sadighi, Sajad Khazal. Front Oncol 2021
33
Theranostic potential of oncolytic vaccinia virus.
Juan J Rojas, Steve H Thorne. Theranostics 2012
Juan J Rojas, Steve H Thorne. Theranostics 2012
33
Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.
Shuya Yano, Hiroshi Tazawa, Hiroyuki Kishimoto, Shunsuke Kagawa, Toshiyoshi Fujiwara, Robert M Hoffman. Int J Mol Sci 2021
Shuya Yano, Hiroshi Tazawa, Hiroyuki Kishimoto, Shunsuke Kagawa, Toshiyoshi Fujiwara, Robert M Hoffman. Int J Mol Sci 2021
33
Turning the corner on therapeutic cancer vaccines.
Robert E Hollingsworth, Kathrin Jansen. NPJ Vaccines 2019
Robert E Hollingsworth, Kathrin Jansen. NPJ Vaccines 2019
33
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
Tao Shi, Xueru Song, Yue Wang, Fangcen Liu, Jia Wei. Front Immunol 2020
Tao Shi, Xueru Song, Yue Wang, Fangcen Liu, Jia Wei. Front Immunol 2020
33
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis.
Avirup Guha, Daniel Addison, Prantesh Jain, Jahir M Gutierrez, Arjun Ghosh, Claire Roddie, Marcos de Lima, Sadeer Al-Kindi, Guilherme H Oliveira. Biol Blood Marrow Transplant 2020
Avirup Guha, Daniel Addison, Prantesh Jain, Jahir M Gutierrez, Arjun Ghosh, Claire Roddie, Marcos de Lima, Sadeer Al-Kindi, Guilherme H Oliveira. Biol Blood Marrow Transplant 2020
33
Novel points of attack for targeted cancer therapy.
Gro Vatne Røsland, Agnete Svendsen Tenfjord Engelsen. Basic Clin Pharmacol Toxicol 2015
Gro Vatne Røsland, Agnete Svendsen Tenfjord Engelsen. Basic Clin Pharmacol Toxicol 2015
33
Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China.
Ruofei Du, Xin Wang, Lixia Ma, Leon M Larcher, Han Tang, Huiyue Zhou, Changying Chen, Tao Wang. BMC Cancer 2021
Ruofei Du, Xin Wang, Lixia Ma, Leon M Larcher, Han Tang, Huiyue Zhou, Changying Chen, Tao Wang. BMC Cancer 2021
33
The Potential of Aptamer-Mediated Liquid Biopsy for Early Detection of Cancer.
Dhruvajyoti Roy, Andreas Pascher, Mazen A Juratli, Judith C Sporn. Int J Mol Sci 2021
Dhruvajyoti Roy, Andreas Pascher, Mazen A Juratli, Judith C Sporn. Int J Mol Sci 2021
33
Serious adverse effects occurring after chemotherapy: A general cancer registry-based incidence survey.
Isabelle Ingrand, Gautier Defossez, Claire Lafay-Chebassier, François Chavant, Aurélie Ferru, Pierre Ingrand, Marie-Christine Pérault-Pochat. Br J Clin Pharmacol 2020
Isabelle Ingrand, Gautier Defossez, Claire Lafay-Chebassier, François Chavant, Aurélie Ferru, Pierre Ingrand, Marie-Christine Pérault-Pochat. Br J Clin Pharmacol 2020
33
A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses.
Neeraj Chhabra, Joseph Kennedy. J Med Toxicol 2022
Neeraj Chhabra, Joseph Kennedy. J Med Toxicol 2022
33
T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road.
Michael D Crowther, Inge Marie Svane, Özcan Met. Cells 2020
Michael D Crowther, Inge Marie Svane, Özcan Met. Cells 2020
33
Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology.
Amit J Sabnis, Trever G Bivona. Trends Mol Med 2019
Amit J Sabnis, Trever G Bivona. Trends Mol Med 2019
33
Oncolytic Virotherapy for Cancer: Clinical Experience.
Shyambabu Chaurasiya, Yuman Fong, Susanne G Warner. Biomedicines 2021
Shyambabu Chaurasiya, Yuman Fong, Susanne G Warner. Biomedicines 2021
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.